Am J Transplant, Volume 21, Suppl 3 Archives - Page 138 of 139 - ATC Abstracts

2021 American Transplant Congress
De Novo Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplant Recipients from the Same Donor: Possible Role of Two Genetic Hits
C. Crane¹, J. Sherbotie², S. Anand³
¹University of California at San Diego, San Diego, CA, ²University of Utah School of Medicine, Salt Lake City, UT, ³Nephrology Associates of Utah, Salt Lake City, UT
*Purpose: Thrombotic microangiopathy (TMA) is an uncommon and potentially serious complication of kidney transplantation. Atypical hemolytic uremic syndrome (aHUS) is a type of TMA most…
2021 American Transplant Congress
Intermediate Outcomes Following Early Inflammatory Changes on Surveillance Biopsies
I. Melgarejo¹, V. Viswanathan², A. Sharma¹, P. Sood¹, C. Puttarajappa¹, N. Shah¹, M. Molinari¹, A. Tevar¹, C. Wu¹, S. Hariharan¹, R. Mehta¹
¹Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Department of Renal-electrolyte, University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: The implications on early inflammatory changes on surveillance biopsies on intermediate and long-term outcomes is unclear.*Methods: Of the 1000 kidney transplant (live donor and…
2021 American Transplant Congress
Development of Novel Multivariable Logistic Regression Model for Predicting Acute Kidney Injury After Liver Transplantation
H. Chen, Y. Nie, Q. Zhao, X. He
Organ Transplant Center,, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: Acute kidney injury (AKI) is a common early complication after liver transplantation, but there are no related predictive tools or models at present. The…
2021 American Transplant Congress
Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
H. Bakhtiari¹, S. Todd², H. Snyder², D. Lo², M. Flynn²
¹Mercer University College of Pharmacy, Atlanta, GA, ²Emory University Hospital, Atlanta, GA
*Purpose: The purpose of this study was to compare outcomes in liver transplant patients maintained on standard calcineurin inhibitor (CNI) therapy with tacrolimus versus those…
2021 American Transplant Congress
Liver Transplant in Adult Recipients Using Pediatric Deceased Donor Liver Grafts
P. Vargas¹, C. Argo², H. Zachary², M. Stotts², N. Intagliata², P. Northup², S. Pelletier¹, J. Oberholzer¹, N. Goldaracena¹
¹Transplant surgery, University of Virginia, Charlottesville, VA, ²Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA
*Purpose: The aim of this study is to evaluate the outcomes following liver transplantation (LT) in adults using grafts from a pediatric deceased donor.*Methods: A…
2021 American Transplant Congress
Machine Learning Informs Utility-Based Non-Directed Living Liver Donor Allocation
K. Bambha¹, J. Perkins¹, M. Sturdevant¹, S. W. Biggins¹, R. Bakthavatsalam¹, P. Healey², A. Dick², J. Reyes¹
¹University of Washington, Seattle, WA, ²Seattle Children's, Seattle, WA
*Purpose: To maximize non-directed living liver donor graft utility, we developed analytic models predicting 10-year graft survival post liver transplant (LT).*Methods: We analyzed OPTN living…
2021 American Transplant Congress
Allocation Changes and Covid Effect on Waiting Time for Liver Transplantation
L. Dageforde¹, Q. Yuan², N. Elias¹
¹Division of Transplantation, Massachusetts General Hospital, Boston, MA, ²Organ Transplant Institute, 8th Medical Center, Chinese PLA General Hospital, Beijing, China
*Purpose: On April 30, 2019 the National Liver Review Board (NLRB) was implemented and patients meeting criteria for hepatocellular carcinoma exception points received a score…
2021 American Transplant Congress
Liver Transplant Outcomes Using Nationally Allocated Grafts
S. Ohara¹, B. Lizaola-Mayo², P. Morgan², D. Das³, J. Wagler⁴, K. S. Reddy², B. Aqel², A. Moss², C. Jadlowiec²
¹Valleywise Health General Surgery Residency Program, Phoenix, AZ, ²Mayo Clinic, Phoenix, AZ, ³Mayo Clinic Alix School of Medicine, Scottsdale, AZ, ⁴John C Lincoln, Phoenix, AZ
*Purpose: There is national variation in acceptance criteria and utilization of livers across transplant centers. Data pertaining to outcomes of liver grafts declined by local…
2021 American Transplant Congress
Thrombotic and Hemorrhagic Complications Associated with Postoperative Anticoagulation After Pediatric Liver Transplantation
C. Lemoine, K. Brandt, R. Superina
Division of Transplant and Advanced Hepatobiliary Surgery, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL
*Purpose: In order to determine the efficacy of post-liver transplant (LT) anticoagulation protocols in reducing the occurrence of arterial thrombosis (HAT) and other vascular complications…
2021 American Transplant Congress
Impact of Positive Donor Cultures on Postoperative Lung Transplantation Infectious Outcomes
A. Curtis, C. Pham, B. P. Pierce
Houston Methodist Hospital, Houston, TX
*Purpose: Transmission risk of microbes present in donor lungs at time of donation to lung transplant recipients (LTR) is unclear. Infection is the second highest…